Woodline Partners’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Sell
860,622
-365,573
-30% -$6.02M 0.04% 457
2026
Q1
$20M Sell
1,226,195
-114,002
-9% -$1.78M 0.08% 345
2025
Q4
$19.9M Buy
1,340,197
+782,605
+140% +$11.1M 0.08% 316
2025
Q3
$7.16M Buy
+557,592
New +$7.43M 0.03% 501
2024
Q4
Sell
-982,522
Closed -$18.5M 990
2024
Q3
$18.5M Sell
982,522
-362,803
-27% -$6.95M 0.16% 205
2024
Q2
$25.4M Buy
1,345,325
+728,508
+118% +$12.4M 0.24% 132
2024
Q1
$10M Buy
+616,817
New +$9.03M 0.09% 270
2023
Q4
Sell
-866,485
Closed -$11.8M 638
2023
Q3
$11.8M Buy
866,485
+626,181
+261% +$9.67M 0.14% 204
2023
Q2
$4.13M Buy
+240,304
New +$3.72M 0.05% 321

Other funds holding SEM

Woodline Partners's SEM Position: Q2 2026 in Review

Woodline Partners reduced its Select Medical (SEM) stake by 30% in Q2 2026, selling an estimated $6.02M and leaving 860,622 shares worth $14.2M. The position accounts for 0.04% of the portfolio, ranked #457.

Woodline Partners first reported a position in SEM in Q2 2023 and has held it in 9 quarters since. The position peaked at $25.4M in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Woodline Partners held 860,622 shares of Select Medical worth $14.2M as of Q2 2026.
  • Woodline Partners sold 365,573 Select Medical shares in Q2 2026, an estimated $6.02M.
  • Select Medical made up 0.04% of Woodline Partners's portfolio in Q2 2026, its #457 holding.
  • Woodline Partners first reported a position in Select Medical in Q2 2023 and has held it in 9 quarters since.
  • Woodline Partners's Select Medical position peaked at $25.4M in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.